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Abstract
Previous research indicates that animals fed a high fat (HF) diet supplemented with disodium ascorbyl phytostanyl
phosphate (DAPP) exhibit reduced mass accumulation when compared to HF control. This compound is a water-
soluble phytostanol ester and consists of a hydrophobic plant stanol covalently bonded to ascorbic acid (Vitamin
C). To provide insight into the mechanism of this response, we examined the in vivo effects of a high fat diet
supplemented with ascorbic acid (AA) in the presence and absence of unesterified phytosterols (PS), and set out to
establish whether the supplements have a synergistic effect in a diet-induced obesity mouse model. Our data
indicate that HF diet supplementation with a combination of 1% w/w phytosterol and 1% w/w ascorbic acid
results in reduced mass accumulation, with mean differences in absolute mass between PSAA and HF control of
10.05%; and differences in mass accumulation of 21.6% (i.e. the PSAA group gained on average 21% less mass
each week from weeks 7-12 than the HF control group). In our previous study, the absolute mass difference
between the 2% DAPP and HF control was 41%, while the mean difference in mass accumulation between the
two groups for weeks 7-12 was 67.9%. Mass loss was not observed in animals supplemented with PS or AA alone.
These data suggest that the supplements are synergistic with respect to mass accumulation, and the esterification
of the compounds further potentiates the response. Our data also indicate that chronic administration of PS, both
in the presence and absence of AA, results in changes to fecal output and food transit time, providing insight into
the possibility of long-term changes in intestinal function related to PS supplementation.
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Introduction
Obesity is characterized by an over-accumulation of adi-
pose tissue that is normally associated with excess calo-
ric intake. Over the last few decades, research in the
field of obesity has lead us far from the concept of adi-
pose tissue as an energy storage depot. We now under-
stand that fat is a secretory tissue, producing a variety
of bioactive substances collectively referred to as adipo-
cytokines. A number of these substances, notably tumor
necrosis factor (TNF) alpha and plasminogen activator
inhibitor type 1, suggest that obesity is essentially an
inflammatory disease, where excess adipose tissue
induces macrophage production and activates the
immune system without a legitimate pathogen [1].
Numerous studies indicate that the dysregulation of
these adipocytokines may directly contribute to obesity-
related diseases [2]. In addition to adipocytokines, the
production of reactive oxygen species (ROS) has also
been shown to be elevated in obesity and diabetes [3,4].
Hyperglycemia, hyperlipidemia and hypercholesterole-
mia, key clinical manifestations of obesity and diabetes,
all promote ROS production through various pathways
[5].
Plant sterols (phytosterols) and their saturated deriva-
tives, phytostanols, are among a growing list of dietary
components that exert a positive effect on hypercholes-
terolemia. It is well established that certain plant sterols
* Correspondence: thornton@zoology.ubc.ca
Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East
Mall, Vancouver, BC, Canada
Thornton et al. Lipids in Health and Disease 2011, 10:107
http://www.lipidworld.com/content/10/1/107
© 2011 Thornton et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.and stanols reduce plasma cholesterol levels, ostensibly
by inhibiting enterocytic cholesterol uptake through
competition with dietary and biliary cholesterol for
absorption [6-8]. The modification of hydrophobic plant
stanols into a water-soluble phytostanol ester, where the
phytostanols were covalently bonded to ascorbic acid
(Vitamin C), was undertaken to combine the hypocho-
lesterolemic properties of the phytostanol with the
potential benefits of an antioxidant [9,10]. The resulting
chemical, disodium ascorbyl phytostanyl phosphate
(DAPP) is a phytostanol analogue that exhibits a more
potent hypocholesterolemic effect than unesterified phy-
tosterols and stanols alone [11-14].
Data from studies examining the hypocholesterolemic
effects of DAPP also indicated that animals treated with
the compound experienced a dose-dependent decrease
in body mass accumulation [11,15]. Further analysis of
this compound-associated mass loss revealed that adi-
pose tissue stores were reduced with no accompanying
reduction in lean body mass [16,17]. When previously
obese animals were treated with 2% w/w dietary diso-
dium ascorbyl phytostanyl phosphate in addition to
their high fat diet (45% kcal from fat), they immediately
began losing adipose tissue and within 8 days, they
achieved a statistically similar body mass to untreated
animals on a low fat diet (10% kcal from fat). After 60
days of compound administration, treated animals
exhibited a 41% decline in total body fat with no adverse
effects on organ mass, femur length, muscle mass or
gross morphology; in addition, a significant increase in
aerobic scope (VO2swim - resting metabolic rate) was
observed. In effect, the compound turned previously
obese mice on a high-fat diet into a low-fat diet pheno-
type [17].
Ingestion of unesterified plant sterols has been
reported to result in loss of adipose stores [18]. Research
also indicates that mice on a high fat diet supplemented
with high doses of ascorbic acid accumulate significantly
less adipose tissue than their non-supplemented coun-
terparts [19-22]. By examining the in vivo effects of diet
supplemented with ascorbic acid in the presence and
absence of phytosterols, we set out to establish whether
the supplements have a synergistic effect in a diet-
induced obesity mouse model, and to investigate possi-
ble mechanisms for the supplement-induced mass loss.
Materials and methods
Animals and Diets
All animal studies were conducted with approval from
the UBC Animal Care Committee. Male C57BL/6 mice
(4 weeks old) were purchased from Charles River
laboratories (St. Constant, Quebec, Canada) and housed
individually with wood shaving bedding. The mice were
kept at a constant temperature of 21°C ± 2°C in a 12 hr
light/dark cycle and had unrestricted access to food and
water throughout the period of the study. Animal mass,
food mass and water intake were recorded once per
week. Metabolic assessment of all animals was initiated
on week 13; therefore only data from the first twelve
weeks was used for mass accumulation analysis.
Following an acclimatization period of eight days on
regular mouse chow, C57Bl/6 mice were randomly
assigned into 4 groups (n = 8) and placed on the diets
for 18 weeks. Using Research Diet’s 45 kcal% fat diet
D12451 as a high fat control (HF), diet supplements
were milled into the HF control diet using either 1% w/
w phytosterol/stanol mixture (85451; Sigma Aldrich,
Oakville, ON; b-sitosterol ~76%, sitostanol ~13%, cam-
pesterol ~8%, campestanol ~1%) for the PS diet, 1% w/
w L-ascorbic acid (A5960; Sigma Aldrich, Oakville, ON)
for the AA diet, or a combination of 1% phytosterol/sta-
nols and 1% L-ascorbic acid for the PSAA diet.
Oxygen Consumption
Animals were evaluated for whole animal metabolic
consumption using indirect flow-through calorimetry
during weeks 13-15. Measurement of oxygen consump-
tion at rest (resting metabolic rate; RMR), and at maxi-
mal swimming rate (VO2swim); were conducted on each
dietary group.
Resting metabolic rate is defined as the lowest average
oxygen consumption at 21 ± 0.2°C over a 5 min period
during the light phase (between 1000 and 1800 h) using
an open flow respirometry system. For RMR assessment,
animals were placed in a sealed black Plexiglas 1075 ml
chamber immersed in a 21 ± 0.2°C water bath as per
methodology outlined in Thornton et al, 2007 [17].
Briefly, outside atmospheric air was pushed through the
chamber at a rate of 800 ml min
-1 (0-1.5 l air pump,
Rena Air 400A; Aalborg Mass Flow controller (0-5 l)). A
subsample of excurrent air was dried and scrubbed of
CO2 and passed through an oxygen analyser (Beckman
OM-11 polarographic oxygen analyzer) at a rate of 300
ml min
-1. Oxygen measurements were recorded each
second via a DI-710 A/D converter and the lowest 5
min was corrected for pressure and temperature, and
then averaged to estimate RMR (Windaq DATAQ soft-
ware). Immediately prior to all metabolic measurements,
body mass was recorded to ± 0.1 g. Mice were not
denied food or water prior to respirometry measure-
ments; however, as most food intake occurs nocturnally,
it is an accepted practice to assume the animal is
approaching a post-prandial state near the end of a
RMR assessment [23,24]. Each animal remained in the
chamber for a minimum of 2 hours to ensure that RMR
had been achieved.
To measure VO2swim, a glass funnel was suspended
over a water bath maintained at 20 ± 0.2°C. The animals
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submerged over the mouse to a predetermined height,
leaving an air volume of 250 ml above the water level.
Room air was introduced into the funnel at a rate of
800 ml/min via a submerged air stone. The air stone
was positioned directly beneath the animal to encourage
active swimming. VO2swim was defined as the highest
oxygen consumption averaged over 2 min of a 5 min
swim trial. A subsample of excurrent air was evaluated
as described above.
Body composition
Whole body fat measurements were carried out on a 7T
animal MRI scanner (Bruker, Germany) on week 16 of
the study. Unanesthetised mice were placed inside a
Plexiglas restrainer, and the restrainer was positioned
inside the bore of the magnet. NMR signal from the
entire body was acquired with a quadrature volume RF
coil tuned to 300MHz. A standard CPMG sequence (TE
= 2.377 ms, TR = 10 s) was used to acquire 256 echoes
from which the T2 decay curve was extracted. The
decay curves were then fit to a double exponential func-
tion using software procedure developed in house with
Igor (WaveMetrics, OR). The ratio of lean tissue/body
fat expressed as weight/weight is then calculated from
the NMR data as described previously [25].
Food transit time
Food transit time was measured by timing the fecal
appearance of Sudan Red III dye administered in the
diet as per Toloza et al, 1991 [26]. Briefly, 300 mg
Sudan red III dye was dissolved in 250 mL of acetone,
and 300 mg of each diet was placed in a glass beaker
and covered with the Sudan red/acetone mixture. The
dyed rations were placed in a fume hood for 72 hours
of evaporation to eliminate the acetone.
To assess the effect of chronic exposure to a HF diet
with or without supplements on food transit time, on
w e e k1 8o ft h ee x p e r i m e n t ,a l lm i c ew e r es w i t c h e dt o
the non-additive HF control diet for 24 hours. At 5 am,
animals were offered the HF control Sudan Red III dyed
diets for two hours, followed by a collection of feces for
twenty hours during ad libidum feeding of HF control
ration. Fecal samples from each collection time point
were dried for a minimum of 48 hours at 60°C and
stored at -20°C until analysis. Fecal pellets were ground
using a mortar and pestle and a ~100 mg aliquot was
placed in a screw top test tube, vortexed with acetone in
a 50:1 w/v ratio and allowed to stand at RT for 30 min.
The samples were centrifuged at 3000 rpm for 3 min
and the quantity of dye in the acetone was assessed
spectrophotometrically at 504 nm. The total amount of
dye eliminated by each mouse during the 20 h collection
period was taken to be 100%, and the data from each
time point are expressed as a percent excretion of the
total dye released over the twenty-hour collection per-
iod. Curves were then fit to a sigmoidal logistic function
using Systat and individual times for 10% through 100%
dye excretion were calculated. Values were indexed to
diet and analysed using a one-way ANOVA; significantly
different group means were identified using Tukey Test.
To establish the acute effect of dietary components on
food transit time, age-matched C57Bl/6 mice raised on
normal chow were randomly assigned a dietary group
and were exposed to the experimental diet for 72 hours
prior to food transit time analysis using above
methodology.
Digestive efficiency
Digestive efficiency is a measure of the amount of che-
mical energy absorbed from the diet. As the diets have
slight differences in caloric value and sterol content, the
values of fecal energy outputs were corrected for con-
sumed phytosterol/stanol amounts. Diets were relatively
isocaloric between the HF control (4.73 kcal/g), AA
(4.69 kcal/g), PS (4.68 kcal/g) and PSAA (4.65 kcal/g)
rations. As it is assumed that phytosterols are not
absorbed, the caloric content of PS is not included in
the above caloric content. Feces were collected over a
period of 72 hr by replacing the shavings in each cage
with a metal grid to facilitate fecal collection. Collected
fecal material was dried overnight in an oven at 60°C,
then stored at -20°C until analysis. Fecal energy content
was assessed using a bomb calorimeter (Adiabatic
calorimeter 1241, Parr Instrument) and corrected for
phytosterol content. Digestive efficiency was calculated
for each animal as the difference between gross energy
consumed and fecal energy output over a 72-hour
period.
Statistical analysis
Statistical analysis was conducted using Sigmastat
(Systat for Windows; v. 5.02). To test effects of diet
and supplement, we used a one-way ANOVA; signifi-
cantly different group means were then separated
using a Tukey Test or Dunnett’sM e t h o da sa p p r o p r i -
ate. Using Sigmaplot, passage rate analysis was con-
d u c t e db yc u r v ef i t t i n gt h ed a t af r o me a c hi n d i v i d u a l
animal and calculating individual output values for 10-
100% dye excretion. Values were indexed to diet and
analysed using a one-way ANOVA in Sigmastat; signif-
icantly different group means were identified using an
ANOVA and a post-hoc Tukey Test; observed differ-
ences between supplement groups and high fat control
were reported. Values with p <0 . 0 5w e r ec o n s i d e r e d
to be significant.
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Growth curves
Over the first 12 weeks of the study, animals fed a HF
diet supplemented with a combination of AA and PS
exhibited a decrease in mass accumulation when com-
pared to control (PSAA group, n = 8, ANOVA followed
by a post-hoc Tukey; p < 0.05, Figure 1a). Animals in
the PSAA group exhibited a lower mass by week 2 and
this difference became significant by week 7 of the study
(n = 7; p < 0.05). There was no significant difference in
caloric intake or water intake between the dietary
groups throughout the growth assessment period (12
weeks; ANOVA, data not shown).
Oxygen Consumption
Metabolic assessment was conducted on animals during
weeks 13-15 of chronic exposure to a HF diet with or
without supplements. Dietary supplementation with PS,
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Figure 1 Mass accumulation of male C57bBl/6 mice exposed to a high fat diet with or without supplements. 1a) Animals in the
phytosterol+ascorbic acid (PSAA) group exhibited a reduction in mass accumulation by week 2 and the difference became statistically
significant by week 7 of the study (n = 7; ANOVA p < 0.05). 1b) Mass accumulation over time for C57Bl/6 animals consuming a high fat diet
with ascorbic acid and phytosterol supplementation (this study) in comparison to animals consuming a high fat control diet with or without
disodium ascorbyl phytostanyl phosphate
(17). Mice chronically exposed to a high fat diet supplemented with 2% w/w phytostanol esterified with
ascorbic acid show a greater decrease in mass accumulation than those consuming a high fat diet supplemented with unesterified phytosterols
and ascorbic acid (1% w/w of each component). * indicates data obtained from this study.
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Page 4 of 14AA or PSAA did not result in significant differences of
RMR or VO2max when compared with HF control (n =
8; ANOVA).
Body Composition
The ratio of lean tissue/body fat expressed as weight/
weight was measured for each animal using MRI. Small
but significant differences were observed between the %
body fat and lean-to-fat ratios in animals in the PS and
PSAA groups when compared to HF control (n = 8;
ANOVA, post-hoc Tukey; % body fat values HF 47.37%;
AA 46.66%; PS 45.32%; PSAA 45.70%; Figure 2).
Fecal Caloric Content
Fecal caloric content was compared both within the
acute and chronic exposure groups as well as between
each dietary group. After corrections were applied to
account for fecal phytosterol content, we did not
observe a significant difference between the caloric con-
tent of the feces between the diets in either the chronic
or acute exposure groups (n = 8; ANOVA). When fecal
caloric content was compared within each dietary group,
we observed a significant reduction in fecal caloric con-
tent with chronic exposure to the HF (p = 0.0002), AA
(p = 0.003) and PS (0.004) diets (n = 8; t-test). The
PSAA group did not demonstrate a significant reduction
in fecal caloric content after chronic exposure to the
supplement (chronic 15.34 ± 0.47 vs acute 16.13 ± 1.06;
p = 0.09; Figure 3).
Food Transit Time
A comparison of the HF control group to the groups
containing additives was undertaken for both the acute
and chronic diet protocols in order to assess the effect
of supplements on food transit time. Each dietary group
was also statistically assessed to establish the effect of
chronic exposure to the diet on food transit time. Spec-
trophotometric assessment of fecal dye content was
expressed as % excretion over the 20-hour assessment
period. Based on the assumption that dye consumption
w a sc o m p l e t ea tt h em i d p o i n to ft h e2 - hp u l s e ,d y e
recovery times for 10% through 100% excretion were
calculated for each animal by curve fitting using a sig-
moidal logistic function. Age-matched C57Bl/6 mice did
*
*
Figure 2 Body fat significantly decreases with the addition of 1% phytosterol to a high fat diet when compared to HF control (HF n =
7, all other groups n = 8; ANOVA followed by a post-hoc Dunnett’s Method). Animals were assessed using magnetic resonance imaging
after 16 weeks on the dietary supplements.
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acute 72-hour exposure to a HF diet with supplements
when compared to animals exposed to the HF control
diet (n = 7, ANOVA; Figure 4a).
After 18 weeks of exposure to PS, AA or PSAA, diet-
ary supplements were withdrawn for 72 hours in order
to assess the chronic effect of additives on transit time.
Placing all animals on the HF diet alone eliminated a
possible intrinsic effect of the dietary supplements on
passage rate. Animals in PS and PSAA exhibited signifi-
cant differences in transit time when compared to the
HF control (ANOVA with post hoc Tukey Test; Figure
4b). The 50% dye recovery values (mean ± SD) for each
diet were eliminated at 9.00 ± 2.17 h (HF; n = 7); 8.39 ±
2.22 h (AA; n = 7); 5.2 ± 1.12 h (PS; n = 3), and 7.02 ±
2.47 (PSAA; n = 4). Some animals in the PS and PSAA
groups did not consume any of the Sudan Red III dyed
ration during the 2-h pulse, therefore the n number is
lower in these groups.
When the acute food transit time was compared to
chronic food transit time for each dietary group, no sig-
nificant change in passage rate was observed for animals
o nt h eH Fo rA Ad i e t s( n=7 ;A N O V A ;F i g u r e5 a ) .
However, a significant decrease in food transit time was
observed for animals in both the PS and PSAA supple-
mented diet groups (n = 3 and 4 respectively; ANOVA
followed by a post-hoc Tukey Test, Figure 5b).
Food consumption and fecal output
Weekly average food consumption and gross energy
intake did not differ significantly between dietary groups
(n = 8; ANOVA). Experimental manipulations (meta-
bolic assessment, swim challenge, fecal collection grids)
were associated with a temporary reduction of food
* *
*
Figure 3 Fecal caloric content in age-matched animals exposed to the diet for 72 hours (acute - closed bars) or 17 weeks (chronic -
open bars). A significant decline in caloric content of the feces was observed in animals chronically exposed to the diet in the HF, AA and PS
groups when compared to an acute 72-hour exposure in age-matched individuals (n = 7; t-test within each dietary group). Asterisks indicate a
significant decline in fecal caloric content is observed in animals exposed to a diet for 17 weeks when compared to acute dietary exposure.
After caloric content was corrected for estimated phytosterol content, no significant difference was observed between the diets within each
exposure.
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Figure 4 Food transit time of age-matched C57Bl/6 mice after an acute (72-hour) and chronic (18 week) exposure to a high fat diet
with or without ascorbic acid or phytosterol supplements. 4a) Acute exposure to dietary supplements did not alter food transit time when
compared to the high fat control (n = 7; ANOVA). 4b) Animals chronically exposed to PS and PSAA supplements exhibited significant differences
in transit time of a HF meal when compared to the HF control (ANOVA with post hoc Tukey Test; n = 7 for HF and AA; n = 3 for PS, n = 4 for
PSAA).
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Page 7 of 14intake; therefore, mass accumulation and food consump-
tion data are reported only for the first 12 weeks of the
study.
Fecal output was assessed under three different condi-
tions. Acute exposure to HF diet with or without sup-
plements in age-matched C57Bl/6 mice indicated that
all diets containing supplements resulted in a significant
increase in fecal output when compared to the HF con-
trol (n = 7; ANOVA followed by a post-hoc Dunnett’s
Method; Figure 6). In animals fed a 1% w/w phytosterol
dietary supplement, a correction factor accounting for
the undigested phytosterol component is applied. Based
on the mean daily food consumption and fecal output
(~3 g and 300 mg, respectively) the fecal mass in ani-
mals consuming a diet containing phytosterol is
expected to be to be ~10% higher due to the non-diges-
tible component.
Animals exposed to the experimental diets with sup-
plements for 17 weeks showed no significant differences
in fecal output when compared to the HF control (n =
7, ANOVA; Figure 7). When the dietary supplements
were removed for 72 hours and animals were fed a HF
diet, a significant decrease in fecal output (>40%) was
observed in the PS and PSAA groups (ANOVA followed
by a post-hoc Dunnett’s Method, Figure 8).
Discussion
Mass accumulation and fecal energy loss
Our data indicate that in a diet-induced obesity C57Bl/6
mouse model, chronic administration of a high fat diet
with 1% w/w phytosterol and 1% w/w ascorbic acid
(PSAA) results in decreased mass accumulation when
compared to either the HF control diet, diets supple-
mented with 1% w/w ascorbic acid (AA), or diets sup-
plemented with 1% phytosterol (PS) alone (Figure 1a;
the decrease in PSAA mass accumulation was significant
from weeks 7-12). The reduced rate of mass gain is not
accompanied by decreased food or water intake, differ-
ences in resting metabolic rate, or alteration of maximal
oxygen consumption (VO2max) when compared to HF
control animals (data not shown; n = 8 for each dietary
group; ANOVA). Interestingly, the decrease in mass
accumulation is not as profound as that observed in our
previous studies where the high fat diet was supplemen-
ted with 2% w/w phytostanol esterified with ascorbic
acid (DAPP; Figure 1b), suggesting that esterification of
the components potentiates the mass loss mechanism
[17]. The mean difference in absolute mass between
PSAA and HF control for the six-week period is 10.05%,
and the mean difference in mass accumulation is 21.6%
(i.e. the PSAA group gained on average 21% less mass
each week from weeks 7-12 than the HF control group).
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Figure 5 Food transit time of a HF diet in animals chronically
exposed to a high fat diet with or without ascorbic acid
supplements is compared to acute (72 hr) exposure transit
times. 5a) In the HF and AA groups, chronic exposure to diets did
not alter food transit time when compared to acute exposure to
the diet for 72 hours in age-matched C57Bl/6 mice (n = 7; ANOVA
followed by a post-hoc Tukey Test). 5b) Chronic exposure to a HF
diet supplemented with phystosterol alone or phytosterol with
ascorbic acid significantly reduced food transit time when
compared to acute exposure to the diet for 72 hours in age-
matched animals (n = 7; significant differences between PS chronic
and acute were observed at 20 - 90%; PSAA chronic and acute at
80 and 90%; ANOVA followed by a post hoc Tukey Test).
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able time period, the mean difference in absolute mass
between the 2% DAPP and HF control was 41%, while
the mean difference in mass accumulation between the
two groups for weeks 7-12 was 67.9%. In animals on the
2% DAPP-supplemented diet, this reduction in mass
accumulation was correlated with adipose tissue reduc-
tion. Magnetic resonance spectroscopy and imaging stu-
d i e so ft h em i c ea tw e e k1 6o ft h ec u r r e n ts t u d y
revealed that animals in the PS and PSAA groups
experienced a slight but significant decline in adipose
tissue mass when compared to the HF control (Figure
2), but only the PSAA group exhibited an accompanying
reduction in mass accumulation. Our data are in con-
currence with Ebine et al (2006), where supplementation
with 2% w/w DAPP resulted in a significant reduction in
mass accumulation in hamsters, whereas supplementa-
tion with 1% w/w unesterified phytostanol alone did not
alter mass accumulation [16].
Ebine and colleagues also indicated that fecal energy
output (adjusted for the phytostanol component) was
not significantly different in animals administered a phy-
tostanol-supplemented diet when compared to the con-
trol diet [16]. Our findings indicate that within both the
acute (72 hour) and chronic (17 weeks) exposure experi-
ments, supplementation with PS, AA or PSAA did not
result in a significant alteration of fecal caloric content
within each exposure experiment when compared to the
HF control (Figure 3). However, a comparison of fecal
energy output from acute exposure vs. chronic exposure
within the same dietary groups revealed a significant
decrease in fecal energy after 17 weeks of exposure to
the HF control, PS and AA diets. A non-significant
decrease in fecal caloric content was also noted in the
PSAA group (t-test; p = 0.09). These data indicate that
long term exposure to a high fat diet, regardless of sup-
plement, results in a decrease in fecal energy and sug-
gests that the animals are absorbing a greater portion of
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Figure 6 Fecal output of age-matched mice after a 72-hour acute exposure to HF diets with or without supplement. As phytosterols are
assumed to be 100% excreted, fecal output for animals in the PS and PSAA groups were corrected to account for the 1% of dietary intake of
non-digestible phytosterol (PS accounts for ~ 10% of fecal output, based on a daily consumption of 1% of 3 g chow and average daily fecal
output of 300 mg). Acute exposure to all HF diets containing supplements resulted in a significant increase in fecal output when compared to
HF control (n = 7; ANOVA followed by a post-hoc Dunnett’s Method).
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[27]. Chronic exposure to a high fat diet has been
shown to enhance intestinal cell proliferation, height of
intestinal villi and to increase enterocytic migration rate
from crypt to villus [28-30]. The reduced rate of mass
accumulation in the PSAA group may be partly due to
amelioration of the increased absorptive capacity that is
associated with chronic dietary HF exposure.
Food transit time and fecal output
Long-term exposure to dietary PS supplementation
resulted in significant changes in energy assimilation
and digestive efficiency. In the 72-hour exposure experi-
ment, acute exposure to dietary supplements did not
alter food transit time (Figure 4a), but did result in an
increased fecal output in all groups when compared to
the HF control (Figure 6). Taken together, these data
suggest that short-term exposure to the dietary supple-
ments results in some degree of interference with diet-
ary uptake, as evidenced by a greater fecal mass with no
alteration in passage rate (data are summarized in Table
1). Acute dietary PS, AA or PSAA supplementation did
not alter the caloric content of the feces when compared
to the HF control (Figure 3, data corrected for estimated
fecal phytosterol output; n = 8, ANOVA), therefore the
net effect of acute exposure on the absorptive process
appears to be an overall decrease in energy assimilation
o faH Fd i e tw h e ni ti sa c c o m p a n i e db yP S ,A Ao r
Figure 7 Fecal output after 17 weeks of chronic exposure to a high fat diet with or without phytosterol or ascorbic acid.A s
phytosterols are assumed to be 100% excreted, fecal output for animals in the PS and PSAA groups were corrected to account for the 1% of
dietary intake of non-digestible phytosterol (PS accounts for ~ 10% of fecal output, based on a daily consumption of 1% of ~3 g chow and
average daily fecal output of ~300 mg). Dietary supplements did not result in a significant difference in fecal output when compared to the
high fat control diet (n = 7; ANOVA followed by a post-hoc Dunnett’s Method).
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with supplements, neither the fecal output (Figure 6),
nor the caloric content of the feces (Figure 3) differed
from the HF control, suggesting that the animals have
accommodated the effects of the supplements over the
course of the chronic exposure (n = 7; ANOVA).
We hypothesize that in the chronic exposure animals,
increased fecal output and thus decreased energy uptake
stimulates intestinal remodeling to compensate for the
energy. When supplements were removed from the diet
and all animals were placed on the HF control diet for
72 hours, no significant difference in the food transit
time of HF control or AA supplemented diet groups
was observed, indicating tha tc h r o n i ce x p o s u r et o1 %
AA supplementation did not induce changes in the
intestine that would result in altered passage rate (Fig-
ure 7a). Interestingly, animals chronically exposed to
diets containing PS or PSAA exhibited a significant and
profound decrease in the transit time of a HF diet (Fig-
ure 7b). In the same animals, fecal output dropped by
more than 40% (Figure 8). In an animal chronically
exposed to PS supplements, these data describe a
*
*
Figure 8 Fecal output from animals switched to a high fat diet for 72 hours after 17 weeks of chronic exposure to a high fat diet with
or without phytosterol or ascorbic acid. As phytosterols are assumed to be 100% excreted, fecal output for animals in the PS and PSAA
groups were corrected to account for the 1% of dietary intake of non-digestible phytosterol (PS accounts for ~ 10% of fecal output, based on a
daily consumption of 1% of 3g chow and average daily fecal output of 300 mg). Chronic exposure to phytosterol supplements in the diet
resulted in a significant decrease in fecal output when additives were withdrawn (n = 7; ANOVA followed by a post-hoc Dunnett’s Method).
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Page 11 of 14situation whereby the HF diet is in contact with the
intestinal absorptive surface for significantly less time,
yet a significantly greater proportion of the mass of the
meal is absorbed when compared to acute exposure, as
evidenced by a reduction in fecal output. These findings
suggest that chronic exposure to PS in the diet alters
the intestine and results in upregulation of its absorptive
capacity. The current opinion in the literature on the
mechanism of phytosterol’s hypocholesterolemic proper-
ties suggests that physical interference of cholesterol
absorption through either competitive positioning in the
micelle, disturbance of micellar formation, or a combi-
nation of both plays a major role [10,31-33]. This mode
of action may also be responsible for alteration of lipid
uptake and result in a proliferation of intestinal trans-
porters to counteract the effect of dietary phytosterol on
energy procurement. When PS supplementation is
removed from the diet, a significant and profound
reduction in fecal output and a decrease in transit time
may be partly explained by a potential increase in sur-
face area and elevation of uptake mechanisms in the
intestinal tract. Further studies involving histological
and immunohistochemical analysis of the intestinal tract
would be necessary to test this hypothesis.
There are a number of studies reporting that animals
on a high fat diet supplemented with high doses of
ascorbic acid accumulate significantly less adipose tissue
than their non-supplemented counterparts [20,21]. This
finding is not unique to ascorbic acid, but is also
observed in response to other antioxidants. In an obese
hamster model, co-administration of a high fat diet with
Extramel microgranules (a melon juice extract coated
with palm oil and rich in antioxidants and particularly
superoxide dismutase) prevented obesity in the high fat-
fed hamsters by decreasing body weight, abdominal fat,
triglyceridemia, insulinemia, insulin resistance, liver
lipids, and nonalcoholic steatohepatitis and preventing
adipokine imbalance [34]. It is also thought that the
antioxidant properties of the Mediterranean diet contri-
bute significantly to its associated decreased risk of obe-
sity and reduced levels of metabolic syndrome when
compared to an isocaloric Western diet [35]. Several
studies have reported a significant inverse relationship
between plasma vitamin C concentrations and degree of
obesity, further supporting a correlation between adi-
pose tissue accumulation and ascorbic acid supplemen-
tation [22,36,37]. Our data did not support the findings
of Campion et al, as the 1% AA supplementation did
not result in a decrease in mass accumulation in DIO
mice [20,38]. However, the potentiation of AA absorp-
tion and thus higher circulating plasma levels may have
been affected by the presence of PS in the diet and its
possible effect on the absorptive capacity of the intes-
tine, which could lead to the observed increased efficacy
of the PSAA combination. Esterification of ascorbic acid
at position 2 protects vitamin C from destruction by
oxidation and may lead to even higher circulating
plasma levels, which may assist in elucidating the
mechanism associated with the esterified ascorbic acid/
phytostanol compound [39,40].
In our previous study using the dietary supplement
disodium ascorbyl phytostanyl phosphate (DAPP), we
observed that animals on a high fat diet with supple-
ment exhibited a significant dose-dependent reduction
in mass accumulation over time when compared to the
HF control group [17]. In the current study, the unes-
terified components of DAPP (ascorbic acid and a phy-
tosterol/phytostanol mixture) were administered
separately and in combination in the presence of a high
fat diet. Although the combination of supplements
resulted in a significant decrease in mass loss when
compared to the high fat diet alone or single-additive
supplementation, the decrease was not as profound as
that observed in the DAPP study. The current study did
Table 1 Summary of findings outlining significant differences in food transit time and fecal output for mice exposed
to a HF diet with or without phytosterol or ascorbic acid supplement for 72 hours (ACUTE) or a 17-20 week exposure
(CHRONIC)
HF AA PS PSAA
FOOD
TRANSIT TIME
FECAL
OUTPUT
FOOD
TRANSIT TIME
FECAL
OUTPUT
FOOD
TRANSIT TIME
FECAL
OUTPUT
FOOD
TRANSIT TIME
FECAL
OUTPUT
ACUTE to HF control n/a n/a NSD ↑ NSD ↑ NSD ↑
CHRONIC to HF control Did not test n/a Did not test NSD Did not test NSD Did not test NSD
CHRONIC on HF to HF
control
n/a n/a NSD NSD ↓↓↓↓
CHRONIC on HF to
ACUTE (paired)
NSD NSD NSD NSD ↓↓↓↓
Animals in the chronic exposure group were switched to a HF control diet for 72 hours; these animals are referred to as “CHRONIC on HF”. Dietary groups with
supplements were compared to the HF control within each exposure experiment and assessed for statistically significant differences. To evaluate long-term
changes to digestive efficiency, all dietary groups in the “CHRONIC on HF” exposure were compared values obtained from animals acutely exposed to the same
dietary groups ("ACUTE”). HF control comparisons to HF control are deemed not applicable (n/a); arrows indicate values are statistically lower or higher than HF
control or dietary pair group. NSD = non-significant difference.
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Page 12 of 14not use the same species of phytostanols that were
employed in the manufacture of DAPP; therefore we
cannot make a direct comparison of esterified phytosta-
nyl vs unesterified phytostanol in the presence of ascor-
bic acid. In addition, the phosphodiester bond may
afford the compound greater protection during the acid-
labile digestive process and allow for absorption in a
more efficacious form. However, the data support the
hypothesis of decreased mass loss associated with diet-
ary supplementation with plant sterols and antioxidants,
and provide some insight into possible mechanisms of
these compounds on energy assimilation in the develop-
ment of obesity in high fat fed mice.
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